‘WHO should’ve researched independently’: CSIR welcomes HCQ trial resumption

Council of Scientific and Industrial Research (CSIR) welcomed WHO's move to resume hydroxychloroquine trials. WHO on Thursday said HCQ will return to solidarity trial for potential treatment for Covid-19. CSIR DG DR Shekhar Mande said WHO should have independently researched before halting HCQ trials.